Kumar Rashmi

Kumar Rashmi is listed in filings as Director at Myriad Genetics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Myriad Genetics, Inc. (MYGN). The current snapshot covers public activity from Aug 20, 2024 to Jun 5, 2026. Reported amounts are shown as $210.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.